AI Insight: Humana's current price at $360.65 is substantially below the weighted fair value of $510.02, indicating significant upside potential supported by a high-confidence DCF valuation. Monte Carlo analysis shows a median valuation (~$609) well above current price, but also high volatility (60.22% CV) with downside risk limited to 8.3%. Financial health scores reveal strong growth amid fair liquidity, profitability, and efficiency, reflecting moderate investment risk against notable valuation opportunity.